Skip to main content
. 2013 Apr 2;8(4):e59966. doi: 10.1371/journal.pone.0059966

Figure 2. The expression of PCNA, CD68 and TGF-β1 after bFGF treatment.

Figure 2

Immunohistochemistry of (A) PCNA, (B) CD68 and (C) TGF-β1 was performed on the indicated day (×200); the histogram represents the positive cells and optical density of the immunohistochemistry results. *P<0.05 and **P<0.01 compared to control group, n = 8.

HHS Vulnerability Disclosure